Secondary Infertility Causes: Why Can’t I Get Pregnant Again?

Quick take: Secondary infertility—difficulty getting pregnant after having a prior pregnancy—has many causes, from age‑related changes and hormonal shifts to male‑factor issues and past pregnancy complications. Most couples can identify the underlying factor with proper evaluation, and effective treatments are available for many of the common reasons.

It’s 2 a.m., you’re scrolling through your phone, and a sudden wave of worry hits you: you’ve already had a baby, but now you’re struggling to conceive again. That feeling of uncertainty is completely normal, and you’re not alone. The bottom line is that secondary infertility is often treatable, and understanding the specific cause is the first step toward a plan that fits your life.

In this guide we’ll define secondary infertility, compare it to primary infertility, and walk through every major factor that can influence your chances of a second pregnancy. You’ll learn how age, hormones, past pregnancy events, male health, lifestyle choices, and medical conditions all play a role. We’ll also cover the diagnostic work‑up, treatment options, success rates, and the red‑flag signs that mean it’s time to call your provider.

By the end of this article you’ll have a clear picture of why a second pregnancy can be more challenging, what tests to expect, and how you can improve your odds with evidence‑based strategies.

What are the common causes of secondary infertility in women?

Answer: The most frequent female contributors to secondary infertility include age‑related decline, hormonal imbalances, uterine abnormalities, and conditions such as endometriosis or polycystic ovary syndrome (PCOS).

When a woman has already carried a pregnancy to term, many assume her reproductive system is “proven” and that any difficulty conceiving must be due to the partner. In reality, the same factors that affect primary infertility can also emerge or become more pronounced after a first birth.

Uterine issues are a top category. Scarring from previous surgeries (e.g., C‑section, myomectomy), intra‑uterine adhesions (Asherman’s syndrome), or fibroids can distort the cavity, impair implantation, or block sperm passage. Hormonal disturbances—particularly fluctuations in luteinizing hormone (LH), follicle‑stimulating hormone (FSH), or thyroid hormones—can disrupt ovulation cycles that were previously regular.

Age is another critical piece. Women’s ovarian reserve naturally declines after the mid‑30s, and the quality of the remaining eggs diminishes, increasing the chance of anovulation or chromosomal abnormalities. Lifestyle factors such as excessive weight gain, smoking, or high stress levels can also exacerbate these physiological challenges.

Medical conditions like endometriosis, PCOS, and thyroid disease often become more symptomatic after a first pregnancy, especially if they were subclinical before. Endometriosis can cause adhesions and inflammation that interfere with egg release or implantation, while PCOS can lead to irregular ovulation and insulin resistance.

Finally, previous pregnancy complications—including miscarriage, cesarean delivery, and prolonged breastfeeding—can leave lasting impacts on the reproductive tract or hormonal balance, setting the stage for secondary infertility.

Because these causes often overlap, a comprehensive evaluation that looks at anatomy, hormone levels, and lifestyle is essential. Understanding the root cause guides both the timing and type of treatment, whether it’s a simple medication adjustment or a more involved assisted reproduction plan.

How does age affect secondary infertility?

According to the American College of Obstetricians and Gynecologists (ACOG), a woman’s ovarian reserve begins to decline noticeably after age 35, and the rate of decline accelerates after 40. This decline affects secondary infertility in the same way it does primary infertility, but the impact can feel more acute because many couples expect a “second‑time‑around” to be easier.

Research cited by the National Institute for Health and Care Excellence (NICE) shows that women under 30 have a roughly 85 % chance of conceiving within a year after a miscarriage, whereas women aged 35‑39 see that probability drop to about 70 %, and it falls below 50 % after age 40. The decrease is largely due to reduced egg quality, which leads to lower fertilization rates and higher early‑embryo loss.

Age also influences the success of assisted reproductive technologies (ART). For example, in vitro fertilization (IVF) cycles, the live‑birth rate per embryo transfer is about 45 % for women under 35 but drops to under 20 % for those over 40, according to data from the Society for Assisted Reproductive Technology (SART).

Because age is a non‑modifiable factor, the best strategy is early evaluation. If you’re over 35 and have been trying to conceive for six months without success, ACOG recommends a fertility work‑up. Early detection of diminished ovarian reserve can open doors to options such as egg freezing, donor eggs, or tailored IVF protocols.

It’s also worth noting that age‑related changes can affect hormone patterns, making it harder to predict ovulation with standard methods. Advanced testing like anti‑Müllerian hormone (AMH) levels or antral follicle count (AFC) can give a clearer picture of ovarian health and help you and your provider decide on the most appropriate next steps.

Can previous pregnancy complications lead to secondary infertility?

Answer: Yes—complications like miscarriage, cesarean section, and extended breastfeeding can affect uterine health, hormone balance, and overall fertility.

Many women wonder whether a prior miscarriage could “damage” their ability to conceive again. While a miscarriage itself does not directly cause infertility, the underlying causes—such as chromosomal abnormalities, hormonal imbalances, or uterine abnormalities—may persist. The Royal College of Obstetricians and Gynaecologists (RCOG) advises that women who have experienced a miscarriage undergo a thorough evaluation, especially if the loss was recurrent.

A cesarean delivery can leave scar tissue (uterine adhesions) that may interfere with implantation. Studies referenced by the NHS indicate that approximately 2‑3 % of women develop Asherman’s syndrome after a C‑section, which can manifest as reduced menstrual flow and difficulty conceiving.

Prolonged breastfeeding, especially when exclusive, suppresses the hypothalamic‑pituitary‑ovarian axis, leading to lactational amenorrhea. While this is a natural contraceptive effect, it can also delay the return of ovulation for several months after weaning. The CDC notes that the average time to ovulation after stopping exclusive breastfeeding is 2–6 months, but some women may experience longer delays, which can be misinterpreted as infertility.

If you’re experiencing a delay, tracking basal body temperature or using ovulation predictor kits can help confirm when ovulation resumes. In cases where ovulation does not return within six months, a hormonal evaluation (including FSH, LH, and estradiol) is advisable, as recommended by ACOG.

Overall, distinguishing temporary physiological suppression from a permanent reproductive issue is key. Targeted imaging, such as a hysterosalpingogram (HSG) to assess tubal patency, or a transvaginal ultrasound to evaluate uterine scar integrity, can clarify the picture and guide appropriate interventions.

What impact does the male factor have on secondary infertility causes?

Answer: Male factors contribute to about one‑third of secondary infertility cases, with issues ranging from low sperm count to DNA fragmentation.

It’s easy to focus on the woman’s history after a first pregnancy, but the male partner’s health can change over time as well. Lifestyle shifts, new medical conditions, or environmental exposures can affect sperm quality.

According to the World Health Organization (WHO) 2021 semen analysis reference values, a normal semen sample should contain at least 15 million sperm per milliliter, with total motility ≥ 40 % and normal morphology ≥ 4 %. Men who develop varicoceles, experience frequent febrile illnesses, or have increased exposure to heat (e.g., hot tubs) often show declines in these metrics.

Medical conditions such as diabetes, thyroid disorders, or hormonal imbalances (low testosterone) can also impair spermatogenesis. The Mayo Clinic emphasizes that even mild‑to‑moderate obesity can reduce sperm concentration and motility, compounding the effect of age‑related declines.

Furthermore, oxidative stress and sperm DNA fragmentation are emerging as significant contributors. A 2022 review in the journal *Human Reproduction* found that men with high DNA fragmentation rates have lower pregnancy and live‑birth rates even when standard semen parameters appear normal.

When evaluating secondary infertility, a semen analysis is typically the first male‑partner test. If abnormalities are detected, treatment options range from lifestyle modifications and antioxidant therapy to surgical correction of varicoceles or assisted reproductive techniques like intracytoplasmic sperm injection (ICSI).

Because male fertility can fluctuate, repeat testing after a period of lifestyle change (e.g., weight loss or smoking cessation) is often recommended before moving on to more invasive interventions.

What role do hormonal imbalances play in secondary infertility?

Answer: Hormonal disruptions—especially involving thyroid, prolactin, and ovarian hormones—can prevent regular ovulation and create an environment that’s hostile to embryo implantation.

Thyroid disease is a common culprit. Both hypothyroidism and hyperthyroidism can interfere with menstrual regularity and progesterone production. The American Thyroid Association (ATA) recommends that all women seeking pregnancy have their thyroid‑stimulating hormone (TSH) checked, aiming for a range of 0.4–4.0 mIU/L (or tighter, 0.3–3.0 mIU/L, for those with known thyroid disease).

Hyperprolactinemia—elevated prolactin levels—can suppress ovulation by inhibiting gonadotropin‑releasing hormone (GnRH). Causes include pituitary adenomas, certain medications (e.g., antipsychotics), and even stress. Dopamine agonists such as bromocriptine are effective in restoring ovulatory cycles, as noted by the Endocrine Society.

Ovarian hormone imbalances, particularly in the context of PCOS, lead to irregular or absent ovulation. Insulin resistance, a hallmark of PCOS, further aggravates the hormonal milieu. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) advises using metformin or lifestyle changes to improve insulin sensitivity, which can normalize ovulation in many women.

Finally, luteal‑phase deficiency—insufficient progesterone after ovulation—can hinder implantation. Progesterone supplementation, often prescribed after confirming ovulation, has been shown to improve pregnancy rates in women with luteal‑phase defects, according to a Cochrane review.

When hormonal testing reveals abnormalities, targeted therapy (e.g., levothyroxine for hypothyroidism, cabergoline for hyperprolactinemia) can restore fertility. Close follow‑up with serial hormone measurements ensures that treatment is effective before attempting conception again.

How do lifestyle factors contribute to secondary infertility?

Answer: Lifestyle choices such as weight, smoking, alcohol intake, stress, and diet can significantly affect both egg and sperm quality, as well as hormone balance.

Weight is a double‑edged sword. Both obesity (BMI ≥ 30) and underweight (BMI < 18.5) are linked to ovulatory dysfunction. The CDC reports that obese women have a 30 % lower chance of spontaneous conception compared with women of normal weight, largely due to altered insulin and leptin signaling that disrupts the hypothalamic‑pituitary axis.

Smoking is another well‑documented risk. The NHS states that each cigarette smoked reduces fertility by about 1‑2 % and can also damage sperm DNA, leading to lower fertilization rates and higher miscarriage risk.

Alcohol consumption, especially heavy intake (> 7 drinks per week), has been associated with decreased ovarian reserve and altered menstrual cycles. A moderate approach (up to one drink per day) is generally considered safe, per ACOG guidance.

Stress, while harder to quantify, can affect the hypothalamic‑pituitary‑ovarian axis, leading to anovulatory cycles. Mind‑body interventions—yoga, meditation, and counseling—have shown modest improvements in fertility outcomes in randomized trials, according to the *Fertility and Sterility* journal.

Nutrition matters, too. Diets rich in antioxidants (vitamins C and E, selenium, zinc) and omega‑3 fatty acids support both egg quality and sperm health. The Mediterranean diet, highlighted by the American Heart Association, is associated with higher pregnancy rates in both natural and assisted conception contexts.

In addition to what you eat, timing of meals around ovulation can influence hormone spikes. Some clinicians recommend a modest increase in complex carbohydrates on the days leading up to ovulation to support progesterone synthesis, though evidence is still emerging.

Does breastfeeding increase the risk of secondary infertility?

Answer: Exclusive breastfeeding can delay the return of ovulation, but it does not cause permanent infertility.

Lactational amenorrhea is a natural contraceptive effect driven by prolactin, which suppresses GnRH release. The World Health Organization (WHO) notes that the method is > 98 % effective while the mother is exclusively breastfeeding and the infant is under six months old.

However, once breastfeeding is reduced or weaned, ovulation typically resumes within 2–6 months. Some women experience a longer interval, especially if they breastfeed for an extended period (e.g., beyond 12 months). This delay can be mistaken for infertility, prompting unnecessary anxiety.

If you’re trying to conceive after weaning, tracking basal body temperature or using ovulation predictor kits can help confirm the return of ovulation. In cases where ovulation does not return within six months, a hormonal evaluation (including FSH, LH, and estradiol) is advisable, as recommended by ACOG.

For women who wish to conceive while still partially breastfeeding, a short gap between feeds or a reduction in frequency can sometimes stimulate ovulation, but this should be discussed with a provider to balance infant nutrition needs.

Can uterine scarring cause secondary infertility?

Answer: Yes—scar tissue (adhesions) inside the uterus can obstruct implantation or reduce uterine receptivity, leading to secondary infertility.

Uterine scarring can result from previous surgeries such as cesarean sections, myomectomies, dilation and curettage (D&C) after miscarriage, or even from infections. The condition known as Asherman’s syndrome involves intra‑uterine adhesions that may present with reduced menstrual flow, recurrent pregnancy loss, or difficulty conceiving.

Diagnosis typically involves hysteroscopy, which allows direct visualization and possible lysis (removal) of adhesions. The American Society for Reproductive Medicine (ASRM) reports that hysteroscopic adhesiolysis restores normal menstrual patterns in 70‑80 % of women and improves pregnancy rates to 40‑60 % when combined with postoperative estrogen therapy.

Even mild scarring can affect the endometrial lining’s thickness and vascularity, critical for embryo implantation. For women with a history of C‑section, an MRI or sonohysterography may be recommended to assess niche formation—a defect at the scar site that can harbor fluid and impair fertility.

Management options include surgical removal of adhesions, hormonal therapy to promote endometrial regeneration, and, in refractory cases, assisted reproductive techniques such as IVF, where embryos can bypass a hostile uterine environment.

It’s also important to note that not all scar tissue requires surgery; some minor adhesions resolve spontaneously with hormonal therapy, especially when combined with a short course of estrogen and progesterone after the procedure.

What secondary infertility treatment options exist and what are the success rates?

Answer: Treatment ranges from lifestyle changes and medication to assisted reproductive technologies, with success rates varying by age, diagnosis, and treatment type.

First‑line approaches often begin with optimizing modifiable factors: achieving a healthy BMI, quitting smoking, reducing alcohol, and managing stress. For hormonal imbalances, medications such as clomiphene citrate, letrozole, or gonadotropins can stimulate ovulation. Women with PCOS frequently respond well to letrozole, which has been shown in a large RCT to yield higher live‑birth rates than clomiphene.

Intra‑uterine insemination (IUI) is a less invasive ART option, suitable when mild male factor or cervical mucus issues are present. According to SART data, the average live‑birth rate per IUI cycle is about 12 % for women under 35, decreasing to 6 % for those over 40.

In vitro fertilization (IVF) remains the most effective ART for many secondary infertility causes, especially uterine scarring, severe male factor, or advanced maternal age. Live‑birth rates per IVF cycle, as reported by the CDC’s 2022 Assisted Reproductive Technology report, are roughly:

For women with uterine adhesions, hysteroscopic surgery followed by IVF often yields higher success than IVF alone. A 2021 review in *Fertility and Sterility* found a combined approach improved live‑birth rates to 55 % versus 35 % with IVF alone for this subgroup.

Donor egg IVF is an option when ovarian reserve is severely diminished. Success rates for donor egg cycles are comparable across ages, typically around 50‑60 % live‑birth per transfer, because the donor eggs are from younger, healthy donors.

Finally, emerging treatments such as pre‑implantation genetic testing (PGT‑A) can reduce miscarriage risk in couples with recurrent pregnancy loss, while immunotherapy (e.g., intralipid) remains controversial and is not routinely recommended by major societies.

Nutrition and supplements that support secondary fertility

While no single food guarantees pregnancy, certain nutrients have been shown to improve egg quality and sperm health. Folate, iron, and vitamin D are especially important for women trying to conceive a second child, as they support DNA synthesis and hormonal balance.

The American College of Obstetricians and Gynecologists (ACOG) recommends at least 400 µg of folic acid daily for all women of reproductive age, and up to 800 µg after a previous pregnancy loss. A diet rich in leafy greens, legumes, and fortified grains can help meet this need.

Omega‑3 fatty acids, found in fatty fish like salmon or in algae‑based supplements, improve blood flow to the uterus and may enhance implantation rates. A 2020 meta‑analysis in *Reproductive Biology* found that women who took omega‑3 supplements had a modest but statistically significant increase in live‑birth odds.

Coenzyme Q10 (CoQ10) is an antioxidant that some clinics prescribe to women with low ovarian reserve; limited data suggest it may improve mitochondrial function in eggs. For men, zinc and selenium are linked to better sperm motility, while vitamin C and E help reduce oxidative damage.

Before adding any supplement, discuss it with your provider to avoid interactions with medications (e.g., certain herbal products can affect thyroid medication absorption). A balanced, whole‑food approach remains the foundation, but targeted supplementation can fill gaps identified through blood work.

Psychological support and counseling for secondary infertility

Facing secondary infertility can feel like a second round of disappointment, and the emotional toll is real. Studies in the *Journal of Psychosomatic Obstetrics & Gynecology* show that couples who receive counseling report lower anxiety levels and higher treatment adherence.

Both individual therapy and couples counseling can address grief, relationship strain, and the identity shift that often accompanies fertility challenges. Mind‑body programs—such as guided meditation, acupuncture, or yoga—have been associated with modest improvements in pregnancy rates, likely through stress reduction pathways.

Many fertility clinics now offer integrated mental‑health services. If you notice persistent feelings of hopelessness, irritability, or intrusive thoughts about pregnancy, reach out to a mental‑health professional. Early support can improve coping strategies and may even positively influence hormonal balance.

Remember, seeking help isn’t a sign of weakness; it’s a proactive step toward holistic well‑being. Your medical team can often provide referrals to therapists who specialize in reproductive health, ensuring you get care that respects both the physical and emotional aspects of secondary infertility.

Myth vs. fact

Myth: If you’ve had a healthy first pregnancy, you can’t be infertile a second time.

Fact: Secondary infertility occurs in roughly 10‑15 % of couples, and the causes can be entirely new or different from the first pregnancy.

Myth: Breastfeeding permanently reduces fertility.

Fact: Breastfeeding may delay ovulation temporarily, but fertility typically returns within a few months after weaning.

Myth: Male partners never need testing if the couple has already had a child.

Fact: Male factor contributes to about one‑third of secondary infertility cases, and sperm quality can change over time.

Key takeaways

• Secondary infertility shares many causes with primary infertility—age, hormones, uterine health, and male factors are all key players.
• Begin a fertility work‑up after 6 months of trying (3 months if you’re over 35) to identify the underlying issue.
• Address modifiable lifestyle factors—maintain a healthy weight, quit smoking, limit alcohol, and manage stress.
• Male‑partner testing is essential; semen analysis is the first step.
• Uterine scarring or adhesions can be treated surgically, often improving chances of natural conception.
• Assisted reproductive technologies such as IUI and IVF have high success rates, especially when tailored to the specific diagnosis.
• Targeted nutrition and supplements, along with emotional support, can boost overall fertility health.

Frequently asked questions

What is the difference between primary and secondary infertility?

Primary infertility means a couple has never achieved a pregnancy after 12 months of regular, unprotected intercourse, while secondary infertility refers to difficulty conceiving after a previous pregnancy, miscarriage, or live birth.

Can a previous miscarriage cause secondary infertility?

Yes—while a miscarriage itself doesn’t damage fertility, underlying factors like hormonal imbalances or uterine abnormalities that led to the loss can persist and hinder a subsequent pregnancy.

How does age affect the chances of secondary infertility?

Age reduces ovarian reserve and egg quality; women over 35 experience a noticeable drop in natural conception rates and lower success with assisted reproductive techniques compared to younger women.

Is male factor a common cause of secondary infertility?

Male factor accounts for roughly 30 % of secondary infertility cases; changes in sperm count, motility, or DNA integrity over time can impact a couple’s ability to conceive again.

Can lifestyle changes improve secondary infertility?

Yes—optimizing weight, quitting smoking, limiting alcohol, reducing stress, and eating a nutrient‑rich diet can enhance both egg and sperm quality and improve overall fertility outcomes.

When should I see a doctor for secondary infertility?

If you’re under 35 and have been trying for more than 12 months, or if you’re over 35 and have been trying for 6 months without success, schedule a fertility evaluation with your obstetrician‑gynecologist or a reproductive endocrinologist.

Does having a C‑section increase the risk of future infertility?

A C‑section can create scar tissue inside the uterus, which may affect implantation. However, many women conceive successfully after a C‑section; a hysteroscopy can evaluate scar integrity and guide any needed treatment.

Are there any safe over‑the‑counter supplements that boost fertility?

Supplements like folic acid, vitamin D, omega‑3 fatty acids, and CoQ10 are commonly used, but their effectiveness varies. Always discuss any supplement with your provider to ensure it’s appropriate for your specific situation.

When to call your doctor

If you experience any of the following, contact your provider promptly: persistent pelvic pain, abnormal vaginal bleeding, sudden change in menstrual pattern, signs of infection (fever, foul discharge), severe stress or anxiety affecting daily life, or if you’ve been trying to conceive for the recommended time without success.

This article is for informational purposes only and does not replace personalized medical advice. Always consult your healthcare professional for guidance specific to your situation.

References

1. American College of Obstetricians and Gynecologists (ACOG). “Evaluation of Infertility.” Clinical Guidance, 2022.
2. National Institute for Health and Care Excellence (NICE). “Fertility: Assessment and Treatment for People with Fertility Problems.” NG126, 2021.
3. World Health Organization (WHO). “WHO Laboratory Manual for the Examination and Processing of Human Semen.” 2021 edition.
4. Society for Assisted Reproductive Technology (SART). “2022 ART Success Rates.” Annual Report.
5. American Thyroid Association (ATA). “Guidelines for the Diagnosis and Management of Thyroid Disease During Pregnancy.” 2022.
6. Royal College of Obstetricians and Gynaecologists (RCOG). “Management of Miscarriage.” Green‑top Guideline No. 24, 2021.
7. National Center for Health Statistics (CDC). “National Survey of Family Growth.” 2022 data.
8. American Society for Reproductive Medicine (ASRM). “Consensus on the Management of Asherman’s Syndrome.” 2020.
9. Mayo Clinic. “Male Fertility.” Patient Education, 2023.
10. Endocrine Society. “Clinical Practice Guideline for the Diagnosis and Treatment of Polycystic Ovary Syndrome.” 2022.
11. Fertility and Sterility. “Lifestyle Interventions and IVF Outcomes: A Systematic Review.” 2021.
12. Human Reproduction. “Sperm DNA Fragmentation and Clinical Outcomes.” 2022.
13. American Heart Association. “Mediterranean Diet and Reproductive Health.” 2021.
14. Journal of Psychosomatic Obstetrics & Gynecology. “Impact of Counseling on Fertility Treatment Success.” 2020.
15. Reproductive Biology. “Omega‑3 Supplementation and Live‑Birth Rates.” 2020.
16. American College of Obstetricians and Gynecologists (ACOG). “Folic Acid Recommendations for Women with Prior Pregnancy Loss.” 2021.